Literature DB >> 12170067

Inhaled alternatives to nitric oxide.

Stuart M Lowson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12170067     DOI: 10.1097/00000542-200206000-00034

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  9 in total

Review 1.  The pediatric cardiology pharmacopeia: 2013 update.

Authors:  Paul Nicholas Severin; Sawsan Awad; Beth Shields; Joan Hoffman; William Bonney; Edmundo Cortez; Rani Ganesan; Aloka Patel; Steve Barnes; Sean Barnes; Shada Al-Anani; Umang Gupta; Yolandee Bell Cheddar; Ismael E Gonzalez; Kiran Mallula; Hani Ghawi; Suhaib Kazmouz; Salwa Gendi; Ra-id Abdulla
Journal:  Pediatr Cardiol       Date:  2012-11-29       Impact factor: 1.655

2.  CCN1 suppresses pulmonary vascular smooth muscle contraction in response to hypoxia.

Authors:  Seon-Jin Lee; Meng Zhang; Kebin Hu; Ling Lin; Duo Zhang; Yang Jin
Journal:  Pulm Circ       Date:  2015-12       Impact factor: 3.017

3.  Epoprostenol treatment of acute pulmonary hypertension is associated with a paradoxical decrease in right ventricular contractility.

Authors:  Steffen Rex; Carlo Missant; Patrick Segers; Rolf Rossaint; Patrick F Wouters
Journal:  Intensive Care Med       Date:  2007-08-21       Impact factor: 17.440

4.  Iloprost inhibits superoxide formation and gp91phox expression induced by the thromboxane A2 analogue U46619, 8-isoprostane F2alpha, prostaglandin F2alpha, cytokines and endotoxin in the pig pulmonary artery.

Authors:  Saima Muzaffar; Nilima Shukla; Clinton Lobo; Gianni D Angelini; Jamie Y Jeremy
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

Review 5.  Acute right ventricular failure--from pathophysiology to new treatments.

Authors:  Alexandre Mebazaa; Peter Karpati; Estelle Renaud; Lars Algotsson
Journal:  Intensive Care Med       Date:  2003-11-15       Impact factor: 17.440

6.  Aerosolized PGE1: a selective pulmonary vasodilator in neonatal hypoxemic respiratory failure results of a Phase I/II open label clinical trial.

Authors:  Beena G Sood; Virginia Delaney-Black; Jacob V Aranda; Seetha Shankaran
Journal:  Pediatr Res       Date:  2004-08-04       Impact factor: 3.756

7.  Comparison of inhaled milrinone, nitric oxide and prostacyclin in acute respiratory distress syndrome.

Authors:  Martin Albert; Daniel Corsilli; David R Williamson; Marc Brosseau; Patrick Bellemare; Stéphane Delisle; Anne Qn Nguyen; France Varin
Journal:  World J Crit Care Med       Date:  2017-02-04

Review 8.  The pediatric cardiology pharmacopoeia: 2004 update.

Authors:  S Barnes; B Shields; W Bonney; J Hardin; R Abdulla
Journal:  Pediatr Cardiol       Date:  2004 Nov-Dec       Impact factor: 1.838

9.  Inhaled PGE1 in neonates with hypoxemic respiratory failure: two pilot feasibility randomized clinical trials.

Authors:  Beena G Sood; Martin Keszler; Meena Garg; Jonathan M Klein; Robin Ohls; Namasivayam Ambalavanan; C Michael Cotten; Monica Malian; Pablo J Sanchez; Satyan Lakshminrusimha; Leif D Nelin; Krisa P Van Meurs; Rebecca Bara; Shampa Saha; Abhik Das; Dennis Wallace; Rosemary D Higgins; Seetha Shankaran
Journal:  Trials       Date:  2014-12-12       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.